YUHSpace: Dept. of Urology (비뇨의학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Urology (비뇨의학교실)

Dept. of Urology (비뇨의학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Comparison of perioperative outcomes between robotic and laparoscopic pa...

Ji Eun Choi ; Ji Hye You ; Dae Keun Kim ; Koon Ho Rha ; Seon Heui Lee EUROPEAN UROLOGY, Vol.67(5) : 891-901, 2015

Nocturnal enuresis: an international evidence based management strategy

K. HJALMAS ; T. ARNOLD ; C.K. YEUNG ; J. VANDE WALLE ; L. ROBSON ; S. RITTIG ... JOURNAL OF UROLOGY, Vol.171(6 Pt 2) : 2545-2561, 2004

Analysis of Intracorporeal Compared with Extracorporeal Urinary Diversio...

Kamran Ahmed ; Shahid A. Khan ; Matthew H. Hayn ; Piyush K. Agarwal ; Ketan K... EUROPEAN UROLOGY, Vol.65(2) : 340-347, 2014

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model	ANNALS OF ONCOLOGY
2022	Prospective randomized controlled trial comparing fulguration versus fulguration and hydrodistension for Hunner-type interstitial cystitis/bladder pain syndrome	WORLD JOURNAL OF UROLOGY
2022	Optimized mechanism for fast removal of infectious pathogen-laden aerosols in the negative-pressure unit	JOURNAL OF HAZARDOUS MATERIALS
2022	External validation of karyotype nomogram to predict karyotype abnormalities in oligospermic men	ANDROLOGIA
2022	Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry	JOURNAL OF UROLOGY
2022	Relapses Rates and Patterns for Pathological T0 After Robot-Assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium	UROLOGY
2022	Characteristics of Patients Who Visit Urologic Outpatient Department via Health Promotion Center	Korean Journal of Urological Oncology
2022	Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer's Disease but Not with Vascular Dementia	WORLD JOURNAL OF MENS HEALTH
2022	Lower Urinary Tract Symptoms are Common After Artificial Urinary Sphincter Implantation	UROLOGY
2022	Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma	GENES
2022	Reproducibility and Step-By-Step Learning Curve of Retroperitoneal Video-Assisted Mini-Laparotomy Surgery for Living Donor Nephrectomy: A Single-Center Experience	EXPERIMENTAL AND CLINICAL TRANSPLANTATION
2022	Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma	PLOS ONE
2022	Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis	ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING
2022	Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study	INTERNATIONAL NEUROUROLOGY JOURNAL(대한배뇨장애요실금학회지)
2022	Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)	JOURNAL OF ENDOUROLOGY
2022	The Delivery of the Recombinant Protein Cocktail Identified by Stem Cell-Derived Secretome Analysis Accelerates Kidney Repair After Renal Ischemia-Reperfusion Injury	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
2022	The First 100 Cases of Endoscopic Combined Intrarenal Surgery in Korea: Matched Cohort Analyses versus Shock-Wave Lithotripsy	YONSEI MEDICAL JOURNAL
2022	Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis	INVESTIGATIVE AND CLINICAL UROLOGY
2022	Outcomes of Retzius-sparing versus conventional robot-assisted radical prostatectomy: A KSER update series systematic review and meta-analysis	PLOS ONE
2022	Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)	CLINICAL CANCER RESEARCH

1 2 3 4 567 8 9 10 11 79

License